10833
It was initially developed by Cardiome Pharma , and the intravenous formulation has been bought for further development by Merck in April 2009 .
 organization: Merck
Given options, please tell me the categories of all the listed entity words.Output format is "type1: word1; type2: word2". 
Option: location, person, organization 
Text: {0} 
 Entities: Merck 
Answer:
 organization: Merck